Search Results - "La Hoz, R.M."

Bedaquiline as Salvage Therapy for Mycobacterium Abscessus Surgical Site and Lung Allograft Infection in a Transplant Recipient by La Hoz, R.M, Le, J, Mohanka, M, Philley, J.V, Kowalske, K, Banga, A, Bollineni, S, Kaza, V, Wait, M, Torres, F

Get full text

(2) Subgroup Safety Analyses in Solid Organ Transplant (SOT) Recipients in a Phase 3 Trial of Maribavir (MBV) versus Investigator-Assigned Therapy (IAT) for Cytomegalovirus (CMV) Infection (Refractory with or without Resistance; R/R) by La Hoz, R.M., Florescu, D., Kumar, D., Saliba, F., Gu, J., Sundberg, A.

“…Conventional treatments (txs) for CMV infection post-SOT are associated with toxicities. In the Phase 3 SOLSTICE trial (NCT02931539) in transplant recipients…”
Get full text

A Multicenter Prospective Registry Study of Lung Transplant Recipients Hospitalized with COVID-19 by Heldman, M.R., Kates, O.S., Multani, A., Steinbrink, J.M., Lewis, A.V., Alexander, B.D., Beaird, O.E., Sehgal, S., Mishkin, A.D., La Hoz, R.M., Blumberg, E.A., Nelson, J., Safa, K., Kotton, C.N., Hemmersbach-Miller, M., Chaudhry, Z.S., Saharia, K., Morillas, J.A., Rakita, R.M., Sait, A.S., Meloni, F., Wilkens, H., Camargo, P., Tanna, S.D., Tomic, R., Ison, M.G., Lease, E.D., Fisher, C.E., Limaye, A.P.

“…Outcomes of lung transplant recipients (LTR) hospitalized for COVID-19 and comparisons to non-lung solid organ transplant recipients (SOTR) are incompletely…”
Get full text